Zhiqiang Li

机构：Beijing University of Chinese Medicine, Taiho Pharmaceutical (Japan), Tsinghua University · ORCID：0000-0003-1492-4995

发表论文 50 篇 · 总被引 535 次 · h-index 12

代表论文

• Use of Artificial Intelligence in Peer Review Among Top 100 Medical Journals (2024 · JAMA Network Open · 被引 64)
• Flavonoid 4,4′-dimethoxychalcone selectively eliminates senescent cells via activating ferritinophagy (2023 · Redox Biology · 被引 34)
• Climate and socio-economic factors drive the spatio-temporal dynamics of HFRS in Northeastern China (2022 · One Health · 被引 25)
• The Spatiotemporal Pattern and Its Determinants of Hemorrhagic Fever With Renal Syndrome in Northeastern China: Spatiotemporal Analysis (2023 · JMIR Public Health and Surveillance · 被引 18)
• Omicron-specific ultra-potent SARS-CoV-2 neutralizing antibodies targeting the N1/N2 loop of Spike N-terminal domain (2024 · Emerging Microbes & Infections · 被引 15)
• Global trends of acupuncture clinical research on analgesia from 2010 to 2023: a bibliometric and visualization analysis (2024 · Frontiers in Neurology · 被引 13)